Cargando…

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts

There are currently no clinical strategies utilizing tumor gene expression to inform therapeutic selection for patients with head and neck squamous cell carcinoma (HNSCC). One of the challenges in developing predictive biomarkers is the limited characterization of preclinical HNSCC models. Patient-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Rex H., Roy, Ritu, Li, Hua, Hechmer, Aaron, Zhu, Tian Ran, Izgutdina, Adila, Olshen, Adam B., Johnson, Daniel E., Grandis, Jennifer R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977000/ https://www.ncbi.nlm.nih.gov/pubmed/36857322 http://dx.doi.org/10.1371/journal.pone.0282177

Ejemplares similares

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
por: Bouhaddou, Mehdi, et al.
Publicado: (2021)

Xenograft models of head and neck cancers
por: Sano, Daisuke, et al.
Publicado: (2009)

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016)

STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020)

Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples
por: Behnert, Astrid, et al.
Publicado: (2021)

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies
por: Stein, Andrew P, et al.
Publicado: (2015)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
por: Kang, Han Na, et al.
Publicado: (2020)

Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
por: Folaron, Margaret, et al.
Publicado: (2019)

Head and Neck Cancer among American Indian and Alaska Native Populations in California, 2009–2018
por: Warren, Brooke R., et al.
Publicado: (2021)

Torch-eCpG: A fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units
por: Kober, Kord M., et al.
Publicado: (2023)

Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
por: Vincent-Chong, Vui King, et al.
Publicado: (2021)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
por: Boerrigter, G. H., et al.
Publicado: (1986)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Nucleic Acid Targeting: Towards Personalized Therapy for Head and Neck Cancer
por: Parsel, Sean M, et al.
Publicado: (2015)

Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer
por: Rong, Chao, et al.
Publicado: (2021)

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma
por: Backes, Clara, et al.
Publicado: (2017)

Influence of Handling Conditions on the Establishment and Propagation of Head and Neck Cancer Patient Derived Xenografts
por: Stein, Andrew P., et al.
Publicado: (2014)

Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties
por: Makita, Haruna, et al.
Publicado: (2021)

Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma
por: Bai, Aiping, et al.
Publicado: (2019)

Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients
por: Abel, Lindsey, et al.
Publicado: (2021)

Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma
por: Wheeler, Sarah E., et al.
Publicado: (2015)

Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
por: Johnson, Daniel E.
Publicado: (2012)

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)

Identification of Mutations in the PYRIN-Containing NLR Genes (NLRP) in Head and Neck Squamous Cell Carcinoma
por: Lei, Yu, et al.
Publicado: (2014)

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
por: Huizing, Fokko J., et al.
Publicado: (2018)

Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2020)

Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer
por: Lee, Tet Woo, et al.
Publicado: (2020)

Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
por: Hu, Fangling, et al.
Publicado: (2021)

Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma
por: Castellano, Lúcio Roberto Cançado, et al.
Publicado: (2022)

Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
por: Pazhani, Jayanthi, et al.
Publicado: (2023)

Comprehensive analysis of transcriptome data for identifying biomarkers and therapeutic targets in head and neck squamous cell carcinoma
por: Jin, Yu, et al.
Publicado: (2020)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

4373 Defining the role of non-canonical PIK3CA mutations in head and neck squamous cell carcinoma
por: Lee, Michelle Ji-Eun, et al.
Publicado: (2020)

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
por: Egloff, Ann Marie, et al.
Publicado: (2009)

Caspase-8 mutations associated with head and neck cancer differentially retain functional properties related to TRAIL-induced apoptosis and cytokine induction
por: Cui, Zhibin, et al.
Publicado: (2021)

Head and Neck Reconstruction
por: Feintisch, Adam M., et al.
Publicado: (2013)

Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.
por: Braakhuis, B. J., et al.
Publicado: (1983)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_bati4jtmba1kl4von172ilscqc